Population Pharmacokinetics of Clozapine and Norclozapine and Switchability Assessment between Brands in Uruguayan Patients with Schizophrenia
Clozapine (CZP) is an atypical antipsychotic agent commonly used in the treatment of schizophrenia. It is metabolized primarily by CYP1A2 enzyme, yielding a pharmacologically active metabolite, norclozapine (NCZP). Significant intra- and interindividual pharmacokinetic (PK) variability for CZP and N...
Main Authors: | Ismael Olmos, Manuel Ibarra, Marta Vázquez, Cecilia Maldonado, Pietro Fagiolino, Gustavo Giachetto |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2019/3163502 |
Similar Items
-
Monitoring of clozapine and norclozapine concentrations in schizophrenia treatment
by: N. V. Baymeeva, et al.
Published: (2018-02-01) -
Steady-State Clozapine and Norclozapine Pharmacokinetics in Maori and European Patients
by: David B. Menkes, et al.
Published: (2018-01-01) -
Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation
by: Farinaz Keshavarzi, et al.
Published: (2020-01-01) -
Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects
by: Natalia Guevara, et al.
Published: (2017-08-01) -
Development of a Population Pharmacokinetic Model for Cyclosporine from Therapeutic Drug Monitoring Data
by: Martín Umpiérrez, et al.
Published: (2021-01-01)